Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 4:53 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 1,237 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Chronic Obstructive Pulmonary Disease COPD Clear all

Conditions: COPD, Emphysema, Sarcopenia
Interventions: Multidisciplinary clinic evaluation, COPD standard of care; Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 40 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Chronic Obstructive Pulmonary Disease
Interventions: BREATHE program, Usual Care; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 40 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: COPD, COPD Exacerbation
Interventions: Nebulizers, Dry Powder Inhaler, Brovana, Pulmicort, Atrovent, Advair Diskus, Spiriva HandiHaler; Device · Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 40 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: PH-797804, Placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 40 Years to 80 Years
Enrollment: 730 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 45
States / cities: Birmingham, Alabama • Jasper, Alabama • Phoenix, Arizona + 33 more

Conditions: COPD
Interventions: Active smoking of Tobacco Hookah for 2 hours, Exposure to tobacco hookah second hand smoke, Visit a win bar; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 21 Years and older
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: UMEC/VI 62.5/25 mcg via ELLIPTA, UMEC 62.5 mcg via ELLIPTA, Salmeterol 50 mcg via DISKUS, Placebo via ELLIPTA, Placebo via DISKUS; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 40 Years and older
Enrollment: 2,696 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 37
States / cities: Phoenix, Arizona • Lincoln, California • Clearwater, Florida + 34 more

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: RESP Biosensor; Device
Lead sponsor: Strados Labs, Inc.; Industry
Eligibility: 35 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania

Conditions: Heart Failure, Coronary Artery Disease, Cancer, Chronic Kidney Diseases, COPD, Obesity, Sickle Cell Disease, Diabetes Mellitus, Type 2
Interventions: Community outreach method; Other
Lead sponsor: Jesse Nodora; Other
Eligibility: 21 Years and older
Enrollment: 9,120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: La Jolla, California

Conditions: HIV Infections, Emphysema, Chronic Obstructive Pulmonary Disease, Pneumocystis
Interventions: Not listed
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 407 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2016
U.S. locations: 2
States / cities: Los Angeles, California • San Francisco, California

Conditions: COPD (Chronic Obstructive Pulmonary Disease), Intersitital Lung Disease
Interventions: MoblO2 controls O2 flow, MoblO2 does not control flow; Other
Lead sponsor: Minnesota HealthSolutions; Industry
Eligibility: 25 Years to 95 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: Tiotropium, Placebo matching Olodaterol, Olodaterol; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 40 Years and older
Enrollment: 1,134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 90
States / cities: Florence, Alabama • Jasper, Alabama • Phoenix, Arizona + 79 more

Conditions: Chronic Obstructive Pulmonary Disease, Chronic Heart Failure
Interventions: Mindful Steps; Behavioral
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 40 Years and older
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: COPD, Healthy Volunteers
Interventions: Airvo 3 with respiratory rate algorithm; Device
Lead sponsor: Fisher and Paykel Healthcare; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Louisville, Colorado

Conditions: Congestive Heart Failure, Asthma, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis
Interventions: Respiratory Sensor measurements; Device
Lead sponsor: Institute of Bioengineering and Bioimaging (IBB); Government
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: COPD (Chronic Obstructive Pulmonary Disease)
Interventions: Photon-counting CT, Energy-integrating CT; Device
Lead sponsor: Duke University; Other
Eligibility: Not listed
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: COPD, Medication Adherence
Interventions: Not listed
Lead sponsor: Johns Hopkins University; Other
Eligibility: 40 Years and older
Enrollment: 314 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 2
States / cities: Newark, Delaware • Baltimore, Maryland

Conditions: Lung Disease
Interventions: lipoaspiration, ADcSVF, Normal Saline IV; Procedure
Lead sponsor: Healeon Medical Inc; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2027
U.S. locations: 1
States / cities: Stevensville, Montana

Conditions: Pulmonary Disease, Chronic Obstructive, Asthma COPD
Interventions: Education and mobile phone text-messaging, Education only; Behavioral · Other
Lead sponsor: Kent State University; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Kent, Ohio

Conditions: Chronic Obstructive Pulmonary Disease
Interventions: Proactive Outreach, No Proactive Outreach; Other
Lead sponsor: Harvard Medical School (HMS and HSDM); Other
Eligibility: Not listed
Enrollment: 19,113 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 3
States / cities: Chicago, Illinois • Louisville, Kentucky • Boston, Massachusetts

Conditions: COPD (Chronic Obstructive Pulmonary Disease)
Interventions: COPD Wellness, COPD Wellness Plus+, Usual Care; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 40 Years to 90 Years
Enrollment: 387 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 3
States / cities: San Francisco, California

Conditions: COPD
Interventions: IN-DEX 1.0 mcg/kg, intranasal saline, IN-DEX 1.5 mcg/kg, intranasal saline, Placebo - Saline; Drug
Lead sponsor: Dayton VA Medical Center; Federal
Eligibility: 45 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Dayton, Ohio

Conditions: Lung Cancer, Nonsmall Cell, COPD, Self-Management, Physical Inactivity, Stress, Quality of Life
Interventions: Breathe Easier; Behavioral
Lead sponsor: University of South Carolina; Other
Eligibility: 21 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: TD-4208, Tiotropium; Drug
Lead sponsor: Mylan Inc.; Industry
Eligibility: 40 Years and older
Enrollment: 1,060 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Easley, South Carolina

Conditions: Chronic Obstructive Pulmonary Disease
Interventions: Lunsekimig; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 40 Years to 80 Years
Enrollment: 1,508 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 4
States / cities: Newport Beach, California • Boynton Beach, Florida • Miami Lakes, Florida + 1 more

Search by objective public record fields.

Implementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD

Improving Patient-Centered Care Delivery Among Patients With Chronic Obstructive Pulmonary Disease

Nebulizer Versus Dry Powdered Inhalers for Chronic Obstructive Pulmonary Disease (COPD)

Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide

Adverse Health Effects of Mainstream and Secondhand Hookah Smoke in NYC Hookah Bars

A 24-week Study to Compare Umeclidinium/Vilanterol (UMEC/VI), UMEC and Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Utility of Remote Lung Auscultation in Transitions of Care After Pulmonary Exacerbations of COPD

COVID-19 Testing in Underserved and Vulnerable Populations

Prevalence and Pathogenesis of Lung Disease in a Large HIV Cohort-coordinating Center

MoblO2 to Maintain Oxygenation

Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®

Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF

Airvo 3 Respiratory Rate Validation Study

Remote Monitoring of High-Risk Patients With Chronic Cardiopulmonary Diseases

Photon-counting CT in Chest Imaging

Medication Adherence Research in COPD Patients

Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders

Impact of a Mobile Phone and Educational Intervention

Racial Inequality in Inhaler Fills for COPD - A Trial of Reduced Cost-Sharing

Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD

Placebo Controlled Evaluation of Sedation and Physiological Response to Intranasal Dexmedetomidine in Severe COPD

Breathe Easier II: A Dyad-based Multiple Behavior Intervention

A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)

A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)